ACUTE Cardiovascular Flashcards
Which meds are vasopressors:
- Norepinephrine
- Epinephrine
- Phenylephrine
- Vasopressin
- Dopamine (at higher doses)
- Midodrine (oral alpha-1 agonist for step-down weaning)
Which meds cause tachycardia
- Epinephrine
- Dopamine
- Dobutamine
- Hydralazine
- Isoproterenol
- Nitroprusside (reflex)
Which meds DO NOT cause tachycardia
- Phenylephrine (may actually cause reflex bradycardia)
- Vasopressin
- Beta-blockers (e.g., Metoprolol)
- Non-DHP CCBs (e.g., Diltiazem)
Which meds result in increased CO
- Milrinone
- Dobutamine
- Dopamine
- Epinephrine
- Digoxin
- Norepinephrine (modestly)
Which meds increase myocyte contractility
(Positive inotropes)
* Digoxin
* Dobutamine
* Epinephrine
* Milrinone
* Levosimendan (calcium sensitizer)
Which meds prolong QT intervals
- Class Ia (e.g., Quinidine, Procainamide)
- Class III (e.g., Amiodarone, Sotalol, Dofetilide)
- Risk of Torsades de Pointes
Which meds would benefit patient with cardiogenic shock
- Milrinone (esp. if on beta-blocker)
- Dobutamine
- Norepinephrine (if hypotensive too)
Which medications are indicated for primary management of acute decompensated heart failure
- Milrinone
- Loop diuretics (e.g., Furosemide)
- Nitroglycerin (if hypertensive with pulmonary edema)
Which medications are not indicated for primary management of acute decompensated heart failure
- Phenylephrine (increases afterload)
- Non-DHP CCBs (e.g., Diltiazem)
- Nifedipine (DHP CCB)
Which meds you’d recommend for patient who has asthma with an underlying arrhythmia
- Avoid beta-blockers (esp. nonselective)
- Use Non-DHP CCBs (e.g., Diltiazem or Verapamil) cautiously (unless HFrEF)
- Digoxin can also help with rate control in Afib
Which meds used to treat junctional tachycardia
- Beta-blockers (if no contraindications)
- Non-DHP CCBs: verapamil, diltiazem
- Amiodarone (in more severe/unstable cases)
Chronic Afib treatment with decreased CO
- Digoxin
- Beta-blockers (e.g., Metoprolol)
- Amiodarone (for rhythm control)
- Avoid Non-DHP CCBs if HFrEF
Class III antiarrhythmic agents: potassium channel blockers
Amiodarone
Dofetilide : strict QT monitoring, oral only
Ibutilide: IV only, rapid cardioversion in afib/flutter
Sotalol: nonselective B-blocker + K channel blocker
* Dronedarone: like amid, rapid conversion afib/flutter
Positive Lusitropic
myocardial relaxation (e.g., beta-agonists ↑ lusitropy)
Bathmotropic
: excitability (threshold potential, not a common clinical term)
Dromotropic
conduction velocity (e.g., beta-blockers ↓ it)
Chronotropic
heart rate (e.g., epinephrine ↑, beta-blockers ↓)
RAAS System Summary
- ↓ perfusion → Renin release
- Renin → Angiotensin I → (via ACE) → Angiotensin II
- Angiotensin II → vasoconstriction + aldosterone release
- Aldosterone → Na⁺/water retention → ↑ BP
midodrine
MOA: alpha agonist
Indications: orthostatic hypotension
Contraindications: supine HTN
milrinone
MOA: PDE3 inhibitor> increases cardiac contractility, decreased vascular resistance
Indications: low output HF (works independently of beta receptors)
Contraindications: risk of arrhythmias, hypotension, HF exacerbation, renal failure
digoxin
MOA: Na⁺/K⁺ ATPase inhibitor> less Na exchange = more Ca in cells = increased contractility
Indications: afib, HFrEF
Contraindications: renal dosing, risk of toxicity
carvedilol
MOA: β/α-blocker
Indications: HFrEF
Contraindications: asthma, bradycardia
nitroglycerin
MOA: NO donor> balanced arterial and venous dilation
Indications: angina, pulmonary edema, preload reduction
Contraindications: headache, tolerance
ARBS
MOA: block AT1 receptors> prevent vasoconstriction and aldosterone release
Indications: HF, HTN
Contraindications: hyperkalemia, pregnancy